Deficiency of vitamin A delays bone healing process in association with reduced BMP2 expression after drill-hole injury in mice

Bone

Volumn 47, Issue 6, 2010, Pages 1006-1012

  Tanaka, Kazuhiro ^a   Tanaka, Shinya ^a,b   Sakai, Akinori ^a   Ninomiya, Tadashi ^c   Arai, Yoshinori ^c,d   Nakamura, Toshitaka ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c MATSUMOTO DENTAL UNIVERSITY   (Japan)

^d NIHON UNIVERSITY   (Japan)

Author keywords

Histomorphometry; In vivo micro CT; Intramedullary callus; Osteoblast

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; COLLAGEN TYPE 1A1; MESSENGER RNA; OSTEOCALCIN; PROTEIN P2; RETINOL; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BODY WEIGHT; BONE DEFECT; BONE DENSITY; BONE INJURY; BONE MARROW CELL; BONE REGENERATION; BONE REMODELING; BONE TRANSPLANTATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIETARY INTAKE; DRILL HOLE INJURY; FEMALE; FEMUR; FRACTURE HEALING; GENE REPRESSION; GESTATIONAL AGE; GROWTH RETARDATION; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETINOL DEFICIENCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

ANIMALS; BIOMECHANICS; BODY WEIGHT; BONE DENSITY; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; FEMALE; FEMUR; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIBIA; VITAMIN A; VITAMIN A DEFICIENCY; WOUND HEALING; X-RAY MICROTOMOGRAPHY;

EID: 78049423299     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.08.016     Document Type: Article

References (36)

1. Morriss-Kay G.M., Sokolova N. Embryonic development and pattern formation. FASEB J 1996, 10:961-968.
2. Niederreither K., Vermot J., Schuhbaur B., Chambon P., Dolle P. Embryonic retinoic acid synthesis is required for forelimb growth and anteroposterior patterning in the mouse. Development 2002, 129:3563-3574.
3. Quemelo P.R., Lourenco C.M., Peres L.C. Teratogenic effect of retinoic acid in swiss mice. Acta Cir Bras 2007, 22:451-456.
4. Lee G.S., Kochhar D.M., Collins M.D. Retinoid-induced limb malformations. Curr Pharm Des 2004, 10:2657-2699.
5. Kirimoto A., Takagi Y., Ohya K., Shimokawa H. Effects of retinoic acid on the differentiation of chondrogenic progenitor cells, ATDC5. J Med Dent Sci 2005, 52:153-162.
6. Power S.C., Lancman J., Smith S.M. Retinoic acid is essential for Shh/Hoxd signaling during rat limb outgrowth but not for limb initiation. Dev Dyn 1999, 216:469-480.
7. Sakai A., Langille R.M. Differential and stage dependent effects of retinoic acid on chondrogenesis and synthesis of extracellular matrix macromolecules in chick craniofacial mesenchyme in vitro. Differentiation 1992, 52:19-32.
8. Frandsen A.M., Becks H. The effect of hypovitaminosis A on bone healing and endochondral ossification in rats. Oral Surg Oral Med Oral Pathol 1962, 15:474-487.
9. Zhou H., Hammonds R.G., Findlay D.M., Fuller P.J., Martin T.J., Ng K.W. Retinoic acid modulation of mRNA levels in malignant, nontransformed, and immortalized osteoblasts. J Bone Miner Res 1991, 6:767-777.
10. Heller L.C., Li Y., Abrams K.L., Rogers M.B. Transcriptional regulation of the Bmp2 gene. Retinoic acid induction in F9 embryonal carcinoma cells and Saccharomyces cerevisiae. J Biol Chem 1999, 274:1394-1400.
11. Helvering L.M., Sharp R.L., Ou X., Geiser A.G. Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes. Gene 2000, 256:123-138.
12. Spoorendonk K.M., Peterson-Maduro J., Renn J., Trowe T., Kranenbarg S., Winkler C., Schulte-Merker S. Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeleton. Development 2008, 135:3765-3774.
13. Nagashima M., Sakai A., Uchida S., Tanaka S., Tanaka M., Nakamura T. Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur. Bone 2005, 36:502-511.
14. Tanaka M., Sakai A., Uchida S., Tanaka S., Nagashima M., Katayama T., Yamaguchi K., Nakamura T. Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. Bone 2004, 34:940-948.
15. Uchida S., Doi Y., Kudo H., Furukawa H., Nakamura T., Fujimoto S. Transient expression of activin betaA mRNA on osteoprogenitor cells in rat bone regeneration after drill-hole injury. Bone 2000, 27:81-90.
16. Scribner K.B., McGrane M.M. RNA polymerase II association with the phosphoenolpyruvate carboxykinase (PEPCK) promoter is reduced in vitamin A-deficient mice. J Nutr 2003, 133:4112-4117.
17. Yamamoto M., Takahashi Y., Tabata Y. Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 2006, 12:1305-1311.
18. Takahashi Y., Yamamoto M., Yamada K., Kawakami O., Tabata Y. Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 2007, 13:293-300.
19. Murakami H., Nakamura T., Tsurukami H., Abe M., Barbier A., Suzuki K. Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy. J Bone Miner Res 1994, 9:1355-1364.
20. Chomczynski P., Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 2006, 1:581-585.
21. Plantalech L., Guillaumont M., Vergnaud P., Leclercq M., Delmas P.D. Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women. J Bone Miner Res 1991, 6:1211-1216.
22. Liu G., Peacock M. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int 1998, 62:286-289.
23. Szulc P., Chapuy M.C., Meunier P.J., Delmas P.D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993, 91:1769-1774.
24. Szulc P., Delmas P.D. Influence of vitamin D and retinoids on the gammacarboxylation of osteocalcin in human osteosarcoma MG63 cells. Bone 1996, 19:615-620.
25. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 2006, 99:1233-1239.
26. Lee K.S., Kim H.J., Li Q.L., Chi X.Z., Ueta C., Komori T., Wozney J.M., Kim E.G., Choi J.Y., Ryoo H.M., Bae S.C. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 2000, 20:8783-8792.
27. Lee M.H., Kim Y.J., Kim H.J., Park H.D., Kang A.R., Kyung H.M., Sung J.H., Wozney J.M., Kim H.J., Ryoo H.M. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 2003, 278:34387-34394.
28. Takagi M., Kamiya N., Takahashi T., Ito S., Hasegawa M., Suzuki N., Nakanishi K. Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells. J Mol Histol 2004, 35:81-90.
29. Shimada K., Suzuki N., Ono Y., Tanaka K., Maeno M., Ito K. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells. Bone 2008, 42:886-893.
30. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
31. Liu T., Gao Y., Sakamoto K., Minamizato T., Furukawa K., Tsukazaki T., Shibata Y., Bessho K., Komori T., Yamaguchi A. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines. J Cell Physiol 2007, 211:728-735.
32. Matsubara T., Kida K., Yamaguchi A., Hata K., Ichida F., Meguro H., Aburatani H., Nishimura R., Yoneda T. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 2008, 283:29119-29125.
33. Song B., Estrada K.D., Lyons K.M. Smad signaling in skeletal development and regeneration. Cytokine Growth Factor Rev 2009, 20:379-388.
34. Zhang C., Cho K., Huang Y., Lyons J.P., Zhou X., Sinha K., McCrea P.D., de Crombrugghe B. Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc Natl Acad Sci USA 2008, 105:6936-6941.
35. Gaur T., Lengner C.J., Hovhannisyan H., Bhat R.A., Bodine P.V., Komm B.S., Javed A., van Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 2005, 280:33132-33140.
36. Banerjee C., Javed A., Choi J.Y., Green J., Rosen V., van Wijnen A.J., Stein J.L., Lian J.B., Stein G.S. Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 2001, 142:4026-4039.